Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor

被引:58
作者
Hoyer-Hansen, G
Pessara, U
Holm, A
Pass, J
Weidle, U
Dano, K
Behrendt, N
机构
[1] Rigshosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
[2] Roche Diagnost GmbH, Pharma Res Penzberg, D-82372 Penzberg, Germany
[3] Royal Vet Univ, Inst Chem, DK-1871 Frederiksberg, Denmark
关键词
glycosylphosphatidylinositol; linker region; phospholipase C treatment; plasminogen activator; proteolytic cleavage;
D O I
10.1042/0264-6021:3580673
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urokinase (uPA) has the striking ability to cleave its receptor, uPAR, thereby inactivating the binding potential of this molecule. Here we demonstrate that the glycosylphosphatidylinositol (GPI) anchor of uPAR, which is attached to the third domain, is an important determinant in governing this reaction, even though the actual cleavage occurs between the first and second domains. Purified full-length GPI-anchored uPAR (GPI-uPAR) proved much more susceptible to uPA-mediated cleavage than recombinant truncated soluble uPAR (suPAR), which lacks the glycolipid anchor. This was' not a general difference in proteolytic susceptibility since GPI-uPAR and suPAR were cleaved with equal efficiency by plasmin. Since the amino acid sequences of GPI-uPAR and suPAR are identical except for the C-terminal truncation, the different cleavage patterns suggest that the two uPAR variants differ in the conformation or the flexibility of the linker region between domains 1 and 2. This was supported by the fact that an antibody to the peptide AVTYSRSRYLE, amino acids 84-94 in the linker region, recognizes GPI-uPAR but not suPAR. This difference in the linker region is thus caused by a difference in a remote hydrophobic region. In accordance with this model, when the hydrophobic lipid moiety was removed from the glycolipid anchor by phospholipase C, low concentrations. of uPA could no longer cleave the modified GPI-uPAR and the reactivity to the peptide antibody was greatly decreased. Naturally occurring suPAR, purified from plasma, was found to have a similar resistance to uPA cleavage as phospholipase C-treated GPI-uPAR and recombinant suPAR.
引用
收藏
页码:673 / 679
页数:7
相关论文
共 48 条
[21]   THE GLYCOSYL-PHOSPHATIDYLINOSITOL ANCHOR OF MEMBRANE-PROTEINS [J].
LOW, MG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 988 (03) :427-454
[22]   UROKINASE AND UROKINASE RECEPTOR EXPRESSION IN SOMATIC-CELL HYBRIDS [J].
MAZZIERI, R ;
HOYERHANSEN, G ;
RONNE, E ;
LOBER, D ;
VAGNARELLI, P ;
RAIMONDI, E ;
DECARLI, L ;
DANO, K ;
MIGNATTI, P .
FIBRINOLYSIS, 1994, 8 (06) :344-352
[23]   Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc - Rapid dissociation of GRB2/SOS-SHC complex is associated with the transient phosphorylation of ERK in urokinase-treated cells [J].
Nguyen, DHD ;
Webb, DJ ;
Catling, AD ;
Song, Q ;
Dhakephalkar, A ;
Weber, MJ ;
Ravichandran, KS ;
Gonias, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :19382-19388
[24]   ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HUMAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS PROENZYME USING A COMBINATION OF MONOCLONAL AND POLYCLONAL ANTIBODIES [J].
NIELSEN, LS ;
GRONDAHLHANSEN, J ;
ANDREASEN, PA ;
SKRIVER, L ;
ZEUTHEN, J ;
DANO, K .
JOURNAL OF IMMUNOASSAY, 1986, 7 (03) :209-228
[25]   TRANSFORMATION OF MOUSE FIBROBLASTS TO METHOTREXATE RESISTANCE BY A RECOMBINANT PLASMID EXPRESSING A PROKARYOTIC DIHYDROFOLATE-REDUCTASE [J].
OHARE, K ;
BENOIST, C ;
BREATHNACH, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03) :1527-1531
[26]   A LIGAND-FREE, SOLUBLE UROKINASE RECEPTOR IS PRESENT IN THE ASCITIC FLUID FROM PATIENTS WITH OVARIAN-CANCER [J].
PEDERSEN, N ;
SCHMITT, M ;
RONNE, E ;
NICOLETTI, MI ;
HOYERHANSEN, G ;
CONESE, M ;
GIAVAZZI, R ;
DANO, K ;
KUHN, W ;
JANICKE, F ;
BLASI, F .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2160-2167
[27]   STRUCTURE-FUNCTION-RELATIONSHIPS IN THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - COMPARISON TO OTHER MEMBERS OF THE LY-6 FAMILY AND SNAKE-VENOM ALPHA-NEUROTOXINS [J].
PLOUG, M ;
ELLIS, V .
FEBS LETTERS, 1994, 349 (02) :163-168
[28]   LIGAND INTERACTION BETWEEN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR PROBED WITH 8-ANILINO-1-NAPHTHALENESULFONATE - EVIDENCE FOR A HYDROPHOBIC BINDING-SITE EXPOSED ONLY ON THE INTACT RECEPTOR [J].
PLOUG, M ;
ELLIS, V ;
DANO, K .
BIOCHEMISTRY, 1994, 33 (30) :8991-8997
[29]   CHEMICAL MODIFICATION OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR USING TETRANITROMETHANE - EVIDENCE FOR THE INVOLVEMENT OF SPECIFIC TYROSINE RESIDUES IN BOTH MOLECULES DURING RECEPTOR-LIGAND INTERACTION [J].
PLOUG, M ;
RAHBEKNIELSEN, H ;
ELLIS, V ;
ROEPSTORFF, P ;
DANO, K .
BIOCHEMISTRY, 1995, 34 (39) :12524-12534
[30]  
PLOUG M, 1993, J BIOL CHEM, V268, P17539